South Korea · Delayed Price · Currency is KRW Jeonjinbio Statistics
Total Valuation
Jeonjinbio has a market cap or net worth of KRW 18.62 billion. The enterprise value is 12.33 billion.
| Market Cap | 18.62B |
| Enterprise Value | 12.33B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Jeonjinbio has 9.06 million shares outstanding. The number of shares has increased by 0.81% in one year.
| Current Share Class | 9.06M |
| Shares Outstanding | 9.06M |
| Shares Change (YoY) | +0.81% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 9.75% |
| Owned by Institutions (%) | n/a |
| Float | 7.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.36 |
| PB Ratio | 1.09 |
| P/TBV Ratio | 1.09 |
| P/FCF Ratio | 20.72 |
| P/OCF Ratio | 18.11 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 87.80, with an EV/FCF ratio of 13.72.
| EV / Earnings | n/a |
| EV / Sales | 0.90 |
| EV / EBITDA | 87.80 |
| EV / EBIT | n/a |
| EV / FCF | 13.72 |
Financial Position
The company has a current ratio of 7.96
| Current Ratio | 7.96 |
| Quick Ratio | 6.69 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1.79% and return on invested capital (ROIC) is -3.95%.
| Return on Equity (ROE) | -1.79% |
| Return on Assets (ROA) | -1.40% |
| Return on Invested Capital (ROIC) | -3.95% |
| Return on Capital Employed (ROCE) | -2.39% |
| Weighted Average Cost of Capital (WACC) | 1.61% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.74 |
| Inventory Turnover | 7.00 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.17% in the last 52 weeks. The beta is -0.48, so Jeonjinbio's price volatility has been lower than the market average.
| Beta (5Y) | -0.48 |
| 52-Week Price Change | -24.17% |
| 50-Day Moving Average | 1,966.14 |
| 200-Day Moving Average | 2,159.66 |
| Relative Strength Index (RSI) | 52.79 |
| Average Volume (20 Days) | 12,270 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Jeonjinbio had revenue of KRW 13.71 billion and -307.04 million in losses. Loss per share was -33.75.
| Revenue | 13.71B |
| Gross Profit | 3.53B |
| Operating Income | -413.26M |
| Pretax Income | -307.04M |
| Net Income | -307.04M |
| EBITDA | 140.45M |
| EBIT | -413.26M |
| Loss Per Share | -33.75 |
Balance Sheet
The company has 6.28 billion in cash and no debt, with a net cash position of 6.28 billion or 693.71 per share.
| Cash & Cash Equivalents | 6.28B |
| Total Debt | n/a |
| Net Cash | 6.28B |
| Net Cash Per Share | 693.71 |
| Equity (Book Value) | 17.02B |
| Book Value Per Share | 1,878.68 |
| Working Capital | 8.52B |
Cash Flow
In the last 12 months, operating cash flow was 1.03 billion and capital expenditures -129.21 million, giving a free cash flow of 898.52 million.
| Operating Cash Flow | 1.03B |
| Capital Expenditures | -129.21M |
| Depreciation & Amortization | 553.71M |
| Net Borrowing | n/a |
| Free Cash Flow | 898.52M |
| FCF Per Share | 99.19 |
Margins
Gross margin is 25.72%, with operating and profit margins of -3.01% and -2.24%.
| Gross Margin | 25.72% |
| Operating Margin | -3.01% |
| Pretax Margin | -2.24% |
| Profit Margin | -2.24% |
| EBITDA Margin | 1.02% |
| EBIT Margin | -3.01% |
| FCF Margin | 6.55% |
Dividends & Yields
Jeonjinbio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.81% |
| Shareholder Yield | -0.81% |
| Earnings Yield | -1.65% |
| FCF Yield | 4.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Jeonjinbio has an Altman Z-Score of 8.68 and a Piotroski F-Score of 2.
| Altman Z-Score | 8.68 |
| Piotroski F-Score | 2 |